AG001EMI

147127-20-6 | Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-

AG001EMI

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	147127-20-6
Catalog Number	AG001EMI(AGN-PC-0PZUPY)
Chemical Name	Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-
EC Number	604-571-2
IUPAC Name	[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
InChI	InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1
InChI Key	SGOIRFVFHAKUTI-ZCFIWIBFSA-N
MDL Number	MFCD00943794
Molecular Formula	C9H14N5O4P
Molecular Weight	287.2123
SMILES	P(=O)(O)(O)CO[C@@H](CN1C2=NC=NC(=C2N=C1)N)C
UNII	W4HFE001U5
Synonyms	(R)-9-(2-phosphonylmethoxypropyl)adenine, 9-(2-phosphonomethoxypropyl)adenine, 9-(2-phosphonylmethoxypropyl)adenine, 9-(2-phosphonylmethoxypropyl)adenine, (+-)-isomer, 9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098, 9-(2-phosphonylmethoxypropyl)adenine, (S)-isomer, 9-PMPA (tenofovir), Disoproxil Fumarate, Tenofovir, Disoproxil, Tenofovir, Fumarate, Tenofovir Disoproxil, tenofovir, tenofovir disoproxil, tenofovir disoproxil fumarate, Viread, Tenofovir, 147127-20-6, PMPA, (R)-9-(2-Phosphonomethoxypropyl)adenine, D,L-Tenofovir, PMPA gel, (R)-PMPA, Apropovir, UNII-W4HFE001U5, (R)-9-[2-(Phosphonomethoxy)propyl]adenine, (R)-(((1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONIC ACID, GS-1278, W4HFE001U5, CHEBI:63625, 9-[(R)-2-(phosphonomethoxy)propyl]adenine, (R)-(1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid, ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid, Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, GS 1275, Q-201787, Viread (prodrug for Tenofovir), Tenofovir gel, [(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methylphosphonic acid, (((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic acid, (R)-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic acid, {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonic acid, (R)-9-(Phosphonomethoxypropyl)adenine, GNA & Tenofovir, HHA & Tenofovir, TFV gel, 9-PMPA, PMPA-(R), Tenofovir [USAN:INN:BAN], [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid, anh. tenofovir, Phosphonic acid, (((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, anhydrous tenofovir, Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, (R)-, tenofovir (anh.), AK-33334, (R)-9-(2-Phosphonoylmethoxypropyl)adenine, Tenofovir (Viread), GS1278, PubChem9452, tenofovir (anhydrous), GS 1278, KS-5021, Tenofovir,TDF,PMPA/, AC1LA9BO, CHEMBL483, EC 604-571-2, SCHEMBL39724, KSC525E7B, Tenofovir gel (GS-1278), DTXSID9040132, Tenofovir, >=98% (HPLC), CTK4C5270, SGOIRFVFHAKUTI-ZCFIWIBFSA-N, BCPP000049, HMS3264H05, ZINC1543475, ABP000917, AC-760, BG0625, CP-558, MFCD00943794, AKOS015856701, AKOS015894941, ACN-029240, AN-1132, API0015388, CS-1609, AJ-78845, AN-29781, BC208449, BR-33334, HY-13910, SC-01187, AB0017664, AX8018435, TR-035738, AM20090678, FT-0601652, ST24033314, (R)-(+)-9-[2-Phosphonylmethoxyethyl]adenine, (R)-9-[2-(phosphonomethoxy) propyl] adenine, C17407, J90012, S-2389, 24230-EP2298783A1, 24230-EP2314590A1, AB01274787-01, AB01274787_02, AB01274787_03, 114611-EP2272516A2, 114611-EP2298783A1, 127T206, SR-01000883934, SR-01000883934-1, BRD-K15891719-001-02-8, [[(1R)-2(6-Amino-9H-Purin-9-Yl)-1-Methylethoxy]Methyl]Phosphonic Acid, [2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID, Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA), Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA), Tenefovir, Truvada, Viread, PMPA prodrug, Tenofovir hydrate, Tenofovir disoproxil, Tenofovir/PMPA, Viread, Tenofovir, ATRIPLA, Atripla (TN), Emtriva (TN), Truvada (TN), Viread (TN), Tenofovir [USAN:INN], Tenofovir Disoproxil Fumarate, D0D9HW, UNII-99YXE507IL, C9H14N5O4P, GS-1275, 9-(2-Phosphonomethoxypropyl)adenine, C9-H14-N5-O4-P, CID464205, (R)-9-(2-Phosphonylmethoxypropyl)adenine, CB10985, CS-O-11175, NCGC00167535-01, A5275, S1401, T3006, Phosphonic acid, [[2-(6-amino-9H-purin-9, A10908, TDF, ;[[(1R)-2(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic Acid, P-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic acid, TFV, Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI), 107021-12-5, 206184-49-8, Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA), Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA),

Complexity	354
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	287.078g/mol
Formal Charge	0
Heavy Atom Count	19
Hydrogen Bond Acceptor Count	8
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	287.216g/mol
Monoisotopic Mass	287.078g/mol
Rotatable Bond Count	5
Topological Polar Surface Area	136A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	-1.6

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H302-H315-H319-H332-H335
Packing Group	Ⅲ
Precautionary statements	P261-P280-P305+P351+P338
UN Code	UN 2811

Certificate of Analysis

Lot Number